Jason Mast from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes - 5 months ago STAT+: Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal - 5 months ago STAT+: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in - 5 months ago STAT+: Could sickle cell someday be treated not with CRISPR, but with a pill? - 5 months ago STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion - 5 months ago ‘Last roll of the dice’ for a near-term HIV vaccine fails - 5 months ago STAT+: $100 billion estimate for Ozempic-style weight loss drugs gets wary eye from analysts - 6 months ago STAT+: New CAR-T company, Brainchild Bio, will focus first on brain tumors in children - 6 months ago STAT+: How sickle cell became the first disease treated by CRISPR - 6 months ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - 6 months ago STAT+: Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial - 7 months ago STAT+: What to know about Sarepta’s upcoming data on its Duchenne gene therapy - 7 months ago STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys - 7 months ago Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics - 7 months ago STAT+: Beam Therapeutics to lay off 20% of its staff, reevaluate programs as it cuts costs - 7 months ago Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines - 7 months ago STAT+: Peter Marks on creating Operation Warp Speed, but for rare diseases - 7 months ago STAT+: Sana to lay off nearly a third of staff, de-prioritize a key program - 7 months ago STAT+: Travere kidney drug narrowly fails confirmatory trial following FDA approval - 8 months ago STAT+: They carry a gene for ALS but aren’t sick. What does medical research owe them? - 8 months ago STAT+: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells - 8 months ago
2	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Prime Medicine, Mukherjee’s Myeloid Therapeutics clash over genome-editing deal - 5 months ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - 6 months ago
4	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - 6 months ago
5	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Sarepta’s Duchenne gene therapy fails to meet primary endpoint in pivotal trial - 7 months ago